Veru (VERU) Common Equity (2010 - 2026)
Veru (VERU) posted Common Equity of $28.38 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 84.9% from $15.34 million a year earlier but down 18.4% from the prior quarter.
Powered by 
Analysis
Veru (VERU) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Veru's Common Equity came in at $18.33 million, down 43.3% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -9.4% (FY2020 to FY2025).
- In prior fiscal years, Veru's Common Equity was $32.32 million in FY2024 (+64.2%), $19.68 million in FY2023 (-76.2%), $82.8 million in FY2022 (-46.4%) and $154.52 million in FY2021 (+413.2%).
- Quarterly Common Equity has run from a low of $15.34 million in fiscal Q3 2025 to a high of $154.52 million in fiscal Q4 2021 over five years.
- On a year-over-year basis, Common Equity has increased in each of the last three quarters, with growth averaging 6.2% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q4 2021, with growth of 413.2%; the weakest was fiscal Q2 2023, with a decline of 84.0%.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was $34.79 million (Q2 2026), $37.12 million (Q1 2026) and $18.33 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Veru | 58.32 Mn | -51.96 Mn | - | 28.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.38 Mn |
| Mar 31, 2026 | 34.79 Mn |
| Dec 31, 2025 | 37.12 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 15.34 Mn |
| Mar 31, 2025 | 21.05 Mn |
| Dec 31, 2024 | 26.63 Mn |
| Sep 30, 2024 | 32.32 Mn |
| Jun 30, 2024 | 37.62 Mn |
| Mar 31, 2024 | 45.21 Mn |
| Dec 31, 2023 | 51.60 Mn |
| Sep 30, 2023 | 19.68 Mn |
| Jun 30, 2023 | 20.65 Mn |
| Mar 31, 2023 | 21.81 Mn |
| Dec 31, 2022 | 49.19 Mn |
| Sep 30, 2022 | 82.80 Mn |
| Jun 30, 2022 | 116.87 Mn |
| Mar 31, 2022 | 136.00 Mn |
| Dec 31, 2021 | 148.00 Mn |
| Sep 30, 2021 | 154.52 Mn |
API Access
Veru Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();